Home/Filings/4/0000950170-25-014808
4//SEC Filing

Barry Douglas 4

Accession 0000950170-25-014808

CIK 0001819133other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 7:30 PM ET

Size

7.3 KB

Accession

0000950170-25-014808

Insider Transaction Report

Form 4
Period: 2025-02-03
Barry Douglas
General Counsel
Transactions
  • Award

    Common Stock

    2025-02-03+27,36371,344 total
  • Award

    Stock Option (Right to Buy)

    2025-02-03+164,175164,175 total
    Exercise: $2.91Exp: 2035-02-03Common Stock (164,175 underlying)
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Documents

1 file

Issuer

Tango Therapeutics, Inc.

CIK 0001819133

Entity typeother

Related Parties

1
  • filerCIK 0001890662

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:30 PM ET
Size
7.3 KB